Facebook
Twitter
LinkedIn
Forward
Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.
|
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
|
Oral chemotherapy has shifted the care of oncology patients from infusion clinics to patients' homes. This shift in care requires healthcare providers to not only manage patients differently but for patients to take on additional responsibilities. Aimee Faso, PharmD, BCOP, CPP, addresses the issues related to the safe use of oral chemotherapy in oncology patients.
|
This course explores two ways to protect today's adolescents from a future cancer diagnosis: HPV vaccination and alcohol use prevention. For each topic, we will examine the latest evidence on cancer risk, address common misconceptions about risk reduction, and preview UNC-based research to advance prevention science in partnership with parents and primary care professionals.
|
Jonathan Sorah, MD, will describes the work-up, characterization, and treatment of cancers of unknown primary and also present data/successes of our undiagnosed cancer clinic and future plans.
|
Joshua Zeidner, MD, presents on "Management of Older Adults with AML: Are We Finally Seeing Light at the End of the Tunnel?"
|
Esteban Peña, MD will present on Cancer Care for Spanish-Speaking Patients.
|
Jason Akulian, MD, MPH, MBA, will present on "Lung Cancer Management in North Carolina"
|
Courtney Evron, PA, will present on Vascular Access
|
Trevor Hackman, MD will present on Why Younger People Are Getting Cancer
|